Psychedelic Spotlight Interview

Psychedelic Spotlight Interview

CEO of Entheon Biomedical, Timothy Ko, discusses how the company plans to utilize the psychedelic compound, DMT, to treat a variety of addictions. Episode Summary In this episode of the Psychedelic Spotlight podcast, we spend some time with Timothy Ko who is the CEO...
BioSpace Movers & Shakers

BioSpace Movers & Shakers

Gyroscope Therapeutics – Jessica Stitt was named chief financial officer of London-based Gyroscope Therapeutics Limited. Most recently, she served as the Vice President of Finance and Operations for MyoKardia, Inc., which was acquired by Bristol Myers Squibb in...
Bloomberg

Bloomberg

Entheon Biomedical Announces Nancy Maher, Special Advisor of Data Science and Regulatory Affairs Senior Pharmaceutical & Technology Executive and Current SVP, Chief Information Officer, North America at Kyowa Kirin International plc., Previously of IBM,...